Medicity has received a second patent for its HIE technology.

The FDA has granted Pathway Medical Technologies' 510(k) clearance to market Jetstream Navitus, an updated revascularization catheter for the treatment of peripheral vascular disease (PVD).

Shine Medical Technologies, a Middleton, Wis.-based startup, has secured an initial $11 million in venture capital funding as part of its bid to develop a manufacturing plant that will assist with the shortage of medical isotopes.

Advanced Cardiac Therapeutics, a developer of temperature-sensing cardiac ablation systems, has received CE mark clearance for its Tempasure cardiac ablation catheter, which offers both saline irrigation and temperature-sensing technology.

Genetic variation in metabolism, food and drug interactions, a narrow therapeutic index and the need for frequent international nationalized ratio (INR) checks are just some of the limitations of warfarin, the primary drug used to prevent stroke in patients with atrial fibrillation. Now, there is a new kid on the block, dabigatran (Pradaxa, Boehringer Ingelheim), which may be more cost-effective and safer.

The Federal Circuit of the U.S. Court of Appeals rejected a bid by Saint-Gobain, a manufacturer of crystals for nuclear imaging, to overturn a District Court decision which found that Saint-Gobain had infringed on Siemens' patented PET technology.

GE Healthcares Discovery NM630, an upgradable SPECT technology, which has a 28-inch bore and a table capable of handling patients up to 500 pounds

Northern California provider John Muir Health has opened the Theresa M. Caygill Breast Health Center, which will offer patient screening, treatment, education and other services.